Genmab — Juli 2018
-
God morgen.
-
-
-
-
http://borsen.dk/nyheder/virksomheder/artikel/1/365701/johnson_johnson_idoemt_kraeft-erstatning_paa_47_mia_dollar.html stor mulighed for yderligere salg af Darzalex - måske de skulle smide lidt frysetørret darzalex i det babypudder, så de på den sikrer side
-
Fredag den 13, vi har fortjent en fredagsnyhed, det er længe siden, vi har haft en
-
i går var torsdag, jeg efterlyste en fredags nyhed
-
Hvor de skrev: 2our findings demonstrate the adaptability of the ACTR platform to function in combination with daratumumab, and bypass the challenges of scFv-based CAR-T cell production to safely and effectively target CD38-positive multiple myeloma"
-
the anti-myeloma activity of ACTR T cells in combination with daratumumab. ACTR T cells mediated robust cytotoxicity, cytokine production, and proliferation in response to a range of daratumumab-opsonized target cell lines. Notably, the target specific killing and cytokine production mediated by ACTR T cells in combination with daratumumab was greater than the activity mediated by daratumumab alone.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind